Hepatic CD4 T Cells Predict Hepatocellular Carcinoma Risk on Metabolic Dysfunction‐Associated Steatohepatitis Patients
United European Gastroenterology Journal · 2026
DOI: 10.1002/ueg2.70159 ↗Kurz gefasst
Fachartikel in der Zeitschrift United European Gastroenterology Journal, 2026. Verfasst von Emilse Rodriguez und 13 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Privado Centro Médico de Córdoba S.A., Córdoba, Argentina. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Liver, CD4-Positive T-Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Commission.
Abstract (Originalsprache)
Background & Aims Metabolic dysfunction‐associated steatohepatitis (MASH) increasingly drives hepatocellular carcinoma (HCC) development. We characterized inflammatory infiltrates in liver biopsies from MASH patients who developed HCC versus controls to identify predictive immune signatures.
Method
Formalin‐fixed paraffin‐embedded (FFPE) liver biopsies from MASH patients were categorized as pre‐HCC MASH ( n = 10) or control MASH ( n = 13) by the ESCALON consortium. Standardized histological analysis and multiplexed immunohistochemistry were performed targeting CD4, CD8, PD1, PDL1, FoxP3, CXCR6, CD3, CD68, and CD20 using a PhenoImager Fusion scanner. Single‐cell RNA‐seq datasets characterized hepatic CD4 T cell heterogeneity. Clinical parameters measured included ALT, AST, GGT, alkaline phosphatase, platelets, and INR.
Results
Pre‐HCC MASH showed inflammation extending from portal to periportal areas versus portal‐only distribution in controls. Analysis of 291,908 cells revealed significantly higher CD4+ density ( p = 0.0243) and CD4+PD1+ cells ( p = 0.017) in pre‐HCC patients, while CD8+ and regulatory T cell densities remained unchanged. Single‐cell RNA‐seq identified potential phenotypic shifts from Th1 cytotoxicity toward tissue‐repair and Th17 CD4+ T cells in MASH livers. Combined immunological and clinical variables (sex, age, CD4+ T cell numbers, ALT, alkaline phosphatase and platelets) achieved excellent predictive performance (ROC‐AUC = 0.944) for HCC development.
Conclusions
Increase in liver CD4+ T cell infiltration characterizes MASH‐to‐HCC progression. These immune signatures combined with clinical parameters demonstrate remarkable predictive value for identifying high‐risk MASH patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hospital Privado Centro Médico de Córdoba S.A., Córdoba, Argentina.
- Medizinische Hochschule Hannover, Hannover, Germany.
- Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI-CONICET), Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
- Centro de enfermedades hepáticas y digestivas (CEHYD), Bogotá, Colombia.
- Institute for Medical Science, University of Toronto, Toronto, Ontario, Canada.
- Department of Medicine, University of Minnesota, Variety Club Research Center, Minneapolis, Minnesota, USA.
ORCID-Profile: Marina Fernandez, Anna Saborowski, Arndt Vogel, Domingo Cesar Balderramo, Andre Boonstra, Pablo Alberto Romagnoli
Förderung
- European Commission
Zitieren
APA
Rodriguez, E., Simon, P., Dhooge, S., Fernandez, M., Calafat, P., Kurpis, M., Nuñez, N., Prieto, J., Saborowski, A., Vogel, A., Debes, J. D., Balderramo, D. C., Boonstra, A., & Romagnoli, P. A. (2026). Hepatic CD4 T Cells Predict Hepatocellular Carcinoma Risk on Metabolic Dysfunction‐Associated Steatohepatitis Patients. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.70159
Vancouver
Rodriguez E, Simon P, Dhooge S, Fernandez M, Calafat P, Kurpis M, et al. Hepatic CD4 T Cells Predict Hepatocellular Carcinoma Risk on Metabolic Dysfunction‐Associated Steatohepatitis Patients. United European Gastroenterology Journal. 2026. doi:10.1002/ueg2.70159
BibTeX
@article{Rodriguez2026,
author = {Rodriguez, Emilse and Simon, Peter and Dhooge, Sabrina and Fernandez, Marina and Calafat, Patricia and Kurpis, María and Nuñez, Nicolás and Prieto, Jhon and Saborowski, Anna and Vogel, Arndt and Debes, José Daniel and Balderramo, Domingo Cesar and Boonstra, Andre and Romagnoli, Pablo Alberto},
title = {Hepatic CD4 T Cells Predict Hepatocellular Carcinoma Risk on Metabolic Dysfunction‐Associated Steatohepatitis Patients},
journal = {United European Gastroenterology Journal},
year = {2026},
doi = {10.1002/ueg2.70159}
}
EUVIMED